New understanding of how we see colors

December 7, 2012 by Lin Edwards report

(Medical Xpress)—Scientists have until now not fully understood how animals see in color, since visual pigments in eyes contain exactly the same chromophore (light absorbing segment of the molecule) and yet can absorb different wavelengths of light.

The chromophore retinal (Vitamin A or retinaldehyde) is used by all animals but, depending on the photoreceptor proteins (opsins) associated with it, the same molecule can absorb a spectrum of colors from blues or even ultraviolet to reds. How a single molecule can do this has until now been uncertain.

Now researchers, led by Prof. Babak Borhan of Michigan State University at East Lansing, set out to try to understand the mechanism by which the opsins change the light of the chromophore retinal. They concentrated their efforts on a found in human retinal photoreceptor cells, , which consists of opsin and chromophore components.

One of the major theories about how retinal works is that because it is strongly positively charged at one end it could distribute this electrostatic charge across the chromophore molecule, and this would enable it to absorb the longer wavelengths at the red end of the spectrum. Another theory held that a change in shape of the chromophore-opsin complex could alter the absorption capabilities.

The problem with testing the theories, Borhan said, is that the have proved difficult to work with. So instead, Borhan and colleagues used human cellular retinol binding protein II, (hCRBPII), a gut protein that binds retinol, which is closely related to retinal but which tolerates mutations more readily.

The team first created a mutation of hCRPBII that could bind retinal. They then changed the distribution of the on the retinal molecule by replacing at the binding site retinal uses on hCRPBII in various ways, and in so doing created a range of pigment proteins.

The team then used spectrophotometry to compare the light entering and leaving the proteins to determine which wavelengths were being absorbed. Using this approach they were able to prove the charge distribution theory was correct and that no change in shape was necessary.

A by-product of the new research is the production of the 11 new artificial pigments, which could be used in tracking proteins or cell types being studied, as well as other possible applications such as in food dyes. One of the new pigments could absorb a red wavelength of 644 nanometers (nm), which is above the theoretical maximum wavelength retinal can absorb (560 nm) and is close to infrared (750 nm +).

The paper was published in the journal Science.

Explore further: Researchers discover mechanism that helps humans see in bright and low light

More information: www.sciencemag.org/content/338/6112/1340.abstract

Related Stories

LEDs illuminate eye for ocular disease screening

August 31, 2010

A new imaging system using six different wavelengths to illuminate the interior of the eyeball (ocular fundus) may pave the way for doctors to easily screen patients for common diseases of the eye, such as age-related macular ...

Why animals don't have infrared vision

June 9, 2011

On rare occasion, the light-sensing photoreceptor cells in the eye misfire and signal to the brain as if they have captured photons, when in reality they haven't. For years this phenomenon remained a mystery. Reporting in ...

Discovery alters conventional understanding of sight

June 23, 2011

A discovery by a team of researchers led by a Syracuse University physicist sheds new light on how the vision process is initiated. For almost 50 years, scientists have believed that light signals could not be initiated unless ...

Scientists solve mystery of the eye

November 17, 2011

(PhysOrg.com) -- Scientists have a good overall understanding of human vision: when light enters our eyes, it is focused by the lens and strikes the retina in the back of the eye. The light causes some of the millions of ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.